Mediwhale
Predict cardiovascular risk and detect retinal abnormalities from a single fundus photo using AI.
What is Mediwhale?
Mediwhale is a non-invasive retinal scanning AI developed in South Korea, featuring its flagship product, Dr. Noon. By analyzing a single fundus image, the system evaluates retinal status to predict future cardiovascular disease risk while simultaneously detecting retinal abnormalities. The entire process requires no blood draws or injections, offering a completely non-invasive screening method.
What problems does it solve?
Traditional cardiovascular risk assessment often requires blood tests and multiple biometric measurements, a tedious process that deters many patients. Mediwhale streamlines this by using a retinal photo as an entry point for risk prediction, making checkups lighter and more accessible. It is ideal for medical institutions looking to integrate cardiovascular risk assessments into routine physical exams or outpatient visits, as well as health service organizations focused on chronic disease prevention.
By starting with fundus imaging, the screening also captures vital clues about eye health. Please note that AI predictions serve as risk assessments and decision-support tools rather than definitive diagnoses; final clinical decisions should always be made by a qualified physician. For settings seeking non-invasive health early-warning systems, Mediwhale offers a way to simplify complex screenings down to a simple photo.
Key Features
- Non-invasive retinal scanning
- Dr. Noon AI analysis engine
- Future cardiovascular disease risk prediction
- Works with a single fundus image
- Retinal abnormality detection
- Blood-free and injection-free screening workflow
Pros
- Non-invasive with no blood draws, leading to high patient acceptance
- Delivers risk predictions using just one fundus image
- Simultaneously screens for cardiovascular risk and retinal health
Cons
- Predictions serve as risk assessments and diagnostic aids, not definitive clinical diagnoses
- Requires compatible fundus imaging equipment and integration into existing clinical workflows
Use Cases
- Health screening centers adding non-invasive cardiovascular risk assessments
- Outpatient clinics providing early risk warnings for chronic disease populations
- Preventative medicine organizations implementing fundus imaging screenings
Editor's Note
Trading a single fundus photo for cardiovascular risk insights makes Mediwhale's non-invasive approach exceptionally appealing for preventative care.
FAQ
Is the Mediwhale screening complicated?
No, it is entirely non-invasive. It only requires a single fundus image with no blood draws or injections, making the process quick and lightweight.
Can it tell me definitively if I will get cardiovascular disease?
It provides future risk predictions and assessments as auxiliary information. Actual diagnoses should always be determined comprehensively by a physician.
Why can an eye exam evaluate cardiovascular risk?
Retinal blood vessels reflect the health of blood vessels throughout the entire body. The AI analyzes these imaging features to estimate related health risks.